REITWAVE.COM Institutional Equity Tear Sheet Generator
Download Vector PDF Export Model (CSV)
REITWAVE.COM | INSTITUTIONAL REAL ESTATE RESEARCH
AS OF: OCTOBER 24, 2026  |  10Y TREASURY: 4.99%  |  SIC 6798

MEDICAL PROPERTIES TRUST INC ($MPT)

Sector: Healthcare Facilities  •  Exchange / CIK: NYSE / 0001287865  •  Properties: 150 Assets
Trading at a 8.2% discount to NAV
Safety Score: 72/100 (Moderate Risk)  |  Credit: BBB

Live Share Price

$2.70
52W Range: $2.61 - $6.47

Valuation Multiples

14.2x P/AFFO
P/FFO: 12.9x  |  FFO/sh: $0.21

Net Asset Value (NAV)

$2.94
Prem/Disc: -8.2%  |  Cap: 6.53%

Dividend Cash Flow

5.56% Yield
$0.15/yr (Quarterly)  |  Payout: 78.9%
Balance Sheet & Debt Maturity Sentry
Net Debt to EBITDAre stands at 5.6x. Portfolio leased occupancy is 90.0% with a weighted average lease term (WALT) of 6.5 years. Senior credit rating of BBB provides institutional capital markets access for debt refinancing.
Recent Dividend Payment History (Last 6 Declarations)
Ex-Dividend Date Record / Pay Date Cash Distribution Status / Corporate Action
2026-09-30 2026-10-15 $0.0375 Regular Distribution
Representative Commercial Asset Concentrations (From SEC Form 10-K Item 2)
Commercial Asset / Property Name Location Rentable Sq Ft Occupancy Implied Asset Valuation
MEDICAL PROPERTIES TRUST INC Flagship Commercial Portfolio United States Nationwide 18,750,000 sq ft (implied) 90.0% $441,000,000
Quantitative Risk & Benchmark Performance (QuantStats • VNQ)
Empirical 252-day trading window compared to Vanguard Real Estate ETF (VNQ) benchmark
METHODOLOGY: QUANTSTATS / CAPM
Beta vs VNQ
0.99
Index Tracking (Market Neutral)
Annualized Alpha (α)
-54.75%
Trailing VNQ
Sharpe Ratio (vs VNQ)
-1.44 vs 0.04
-1.48 Spread
Max Drawdown (1-Yr)
-53.6% vs -11.4%
-42.2% vs VNQ
MPT vs VNQ QuantStats Performance & Underwater Drawdown
Quantitative Risk & Return Metric MPT VNQ (Benchmark) Institutional Delta / Spread
Beta (β) vs VNQ
Covariance sensitivity to US REIT market
0.99 1.00 -0.01 (Index Tracking (Market Neutral))
Annualized Alpha (α)
Excess CAPM risk-adjusted performance
-54.75% 0.00% (Baseline) Trailing VNQ
Sharpe Ratio (Rf = 4.5%)
Annualized excess return per unit of volatility
-1.44 0.04 -1.48
Sortino Ratio
Downside semi-variance risk-adjusted return
-1.48 0.03 -1.51
Annualized Volatility (σ)
Standard deviation of daily price returns × √252
37.6% 13.9% +23.7% (Higher Volatility)
Maximum Drawdown (1-Year)
Peak-to-trough capital decline over trailing 12M
-53.6% -11.4% -42.2% vs VNQ
1-Year Trailing Return (CAGR)
Compounded annual growth rate
-43.4% 4.1% -47.5% Spread
R-Squared (R²) & Correlation
Statistical correlation coefficient against VNQ
R² 0.14 Corr: 0.37 14% variance explained by VNQ
Trading Session Win Rate
Percentage of positive daily closing sessions
39.6% 51.6% -12.0% vs Benchmark
QuantStats Analytical Synthesis: MPT displays a Beta of 0.99 relative to VNQ with 0.14 R² correlation. Annualized volatility is 37.6% (23.7% higher than VNQ at 13.9%). Trailing 12-month Alpha stands at -54.75% (Trailing VNQ) with a Sharpe ratio of -1.44 against 0.04 for VNQ, and a maximum drawdown of -53.6%.
SEC CIK: 0001287865  |  Principal Executive Officer: Executive Leadership / MEDICAL Corp  |  Total PEO Compensation: Reported in DEF 14A (N/A)
Official SEC Accession: 0001287865-26-000001
CONFIDENTIAL INSTITUTIONAL TEAR SHEET • REITWAVE.COM (v1.0.0) • Data Sources: SEC EDGAR Form 10-K / DEF 14A, PR Newswire, Bloomberg/CBRE Comps. For institutional and accredited investor due diligence. Not a solicitation or investment recommendation.